Docrates Cancer Center, based in Helsinki, Finland, is a leading international treatment facility specialising in the diagnostics, treatment and follow-up of cancers. The hospital opened its doors in 2007. In 2009, a brand new hospital was built in Jätkäsaari, Helsinki, designed to meet our requirements. Located in the immediate vicinity of the city centre, it provides comprehensive service for cancer patients. Read more about the hospital’s history. At Docrates, cancer patients receive individual service under one roof throughout the duration of the treatment and follow-up. We have harnessed our state-of-the-art technology and the uncompromising competence of our cancer treatment specialists for the best benefit of our patients – accompanied by genuine caring. At Docrates, each patient is assigned a personal care team, personal doctor and primary nurse, who all support patients and their families and are easy to reach. Read more about examinations and treatments and Docrates’ philosophy. Docrates is a completely Finnish-owned private hospital. The largest owner is Aava Terveyspalvelut Oy. The other owners include founder shareholders, minor shareholders and a number of Finnish family-owned companies. Approximately 30% of our patients come from outside of Finland; so far, we have received patients from over 60 different countries. This makes Docrates a very important exporter of health care services. Docrates is the only private cancer hospital in the Nordic countries.
Oncology
- Brachytherapy — $0
- Brachytherapy for prostate cancer — from $53,066
- Breast reconstruction after mastectomy — ≈ $10,952
- Chemotherapy for bladder cancer — $0
- Chemotherapy for bone cancer — $0
- Chemotherapy for brain cancer — $0
- Chemotherapy for colorectal cancer — $0
- Chemotherapy for endometrial cancer — $0
- Chemotherapy for gallbladder cancer — $0
- Chemotherapy for kidney cancer — $0
- Chemotherapy for leukemia — $0
- Chemotherapy for liver cancer — $0
- Chemotherapy for lung cancer — $0
- Chemotherapy for lymphoma — $0
- Chemotherapy for melanoma — $0
- Chemotherapy for myeloma — $0
- Chemotherapy for neuroblastoma — $0
- Chemotherapy for neuroendocrine tumours (NETs) — $0
- Chemotherapy for non-melanoma skin cancer — $0
- Chemotherapy for ovarian cancer — $0
- Chemotherapy for pancreatic cancer — $0
- Chemotherapy for prostate cancer — $0
- Chemotherapy for soft tissue sarcoma — $0
- Chemotherapy for stomach cancer — $0
- Chemotherapy for testicular cancer — $0
- Chemotherapy for vaginal cancer — $0
- Chimeric antigen receptor (CAR) T-cell therapy — $0
- Double preventive mastectomy — ≈ $14,659
- External beam radiotherapy (EBRT) — $0
- Hormone therapy for breast cancer — $0
- Hormone therapy for ovarian cancer — $0
- Immune checkpoint inhibitors — $0
- Interstitial chemotherapy for brain tumors — $0
- Lumpectomy — ≈ $7,067
- Monoclonal antibodies therapy (mAbs) — $0
- Natural killer (NK) cell therapy — $0
- Needle biopsy — ≈ $1,422
- Nipple and areola reconstruction — ≈ $7,583
- Partial mastectomy — from $19,191
- Radiation therapy — $0
- Radiation therapy for breast cancer — from $21,750
- Radical mastectomy — from $16,915
- Radionuclide therapy — $0
- Radiotherapy for prostate cancer — from $34,476
- Simple mastectomy — from $16,915
- Subcutaneous mastectomy — ≈ $13,635
- Surgical breast biopsy — ≈ $4,706
- TRAM flap breast reconstruction — ≈ $78,910
- Total skin electron therapy (TSET) — $0
- Tumor-infiltrating lymphocyte (TIL) therapy — $0
- Vacuum-assisted breast biopsy — ≈ $3,184
